I r v i n g Sunshine 4173 Hubbartt Drive, Palo A l t o , CA 94306 USA A b s t r a c t -S o c i e t y makes ever i n c r e a s i n g demands f o r more s e n s i t i v e , s p e c i f i c , q u a n t i t a t i v e analyses o f t h e many substances t h a t a f f e c t the community's h e a l t h and well-being.
S c i e n t i s t s have responded t o these demands by adapting advanced technology t o achieve these goals. Automated equipment t h a t simultaneously analyzes many specimens f o r several analytes w i t h e x c e l l e n t accuracy and s p e c i f i c i t y i s now i n common use. The necessary h i g h s e n s i t i v i t y r e q u i r e d t o d e t e c t nanogram and picogram q u a n t i t i e s can be achieved u s i n g mass spectrometry coupled t o GC, HPLC and SCF. Coupled t o t h e t e c h n i c a l advanced i s an increasing awareness t h a t many substances, produced and used as racemates, may be more e f f e c t i v e i f t h e more a c t i v e anantiomer i s used. C h i r a l separation o f these entantiomers enables t h e i n v e s t i g a t i o n o f t h e i r r e s p e c t i v e a c t i v i t i e s . T h i s could lead t o more e f f e c t i v e use, i f t h e necessary separation process could be performed economically. Succeeding speakers w i l l address these technologic advances.
NEW TECHNOLOGY IN T D M AND TOXICOLOGY
I s my p a t i e n t poisoned? t o help answer these questions w i t h i n c r e a s i n g frequency. t o the f i r s t question i s t h e physicians c l i n i c a l experience. t h e i r physical examination and t h e i r assessment o f t h e p a t i e n t ' s h i s t o r y i s s u f f i c i e n t t o e s t a b l i s h a diagnosis and they i n s t i t u t e the necessary supportive therapy. do they request a s t a t t o x i c o l o g i c a l a n a l y s i s o f blood and/or u r i n e t o c o n f i r m t h e i r presumptive diagnosis. h e l p f u l data i n r e a l time. T h i s a t t i t u d e i s understandable because t o o o f t e n t h e l a b o r a t o r y i s n o t prepared t o analyze specimens f o r t h e many substances t h a t may be involved. Very few l a b o r a t o r i e s have t h e experienced s t a f f and elegant equipment e s s e n t i a l t o perform t h e r e q u i r e d analyses 24 hours a day, every day o f t h e year. problem, some physicians request a s t a t a n a l y s i s f o r the s p e c i f i c substances they t h i n k may be involved. t h e r e s u l t s obtained from a comprehensive t e s t i n g program used i n t h e l a b o r a t o r y as a r o u t i n e procedure. 30% o f the analyses i n d i c a t e d another unsuspected drug was found i n a d d i t i o n t o the ordered drug, i n 20% o f t h e analyses an unsuspected drug was present, and i n 16% o f the requests no t o x i c substance was detected. a b i l i t y t o c o r r e c t l y i d e n t i f y t h e agent(s) i n v o l v e d i n a suspected poisoning i s l e s s than optimal and t h a t a comprehensive t o x i c o l o g i c a l a n a l y s i s can be h e l p f u l . What i s the present s t a t e o f t h e a r t ? Can r e a l i s t i c data be provided a t reasonable cost, i n r e a l time, by t e c h n o l o g i s t s w i t h l i m i t e d t r a i n i n g ? A resounding YES i s t h e answer. A comprehensive t o x i c o l o g i c a l a n a l y s i s i s n o t f e a s i b l e . A r o u t i n e a n a l y s i s i s possible. It should i n c l u d e those drugs f o r which a n t i d o t e s a r e a v a i l a b l e and those drugs whose c l i n i c a l e f f e c t s a r e a f u n c t i o n o f t h e i r concentration i n a u s e r ' s blood. Included i n t h e f i r s t group are acetaminophen, methanol, ethylene gycol, cyanides, carbon monoxide, opioids, organic phosphates, and the various heavy metals. I n t h e second group one would i n c l u d e t h e sedatives, t h e benzodiazepines, t h e t r i c y c l i c antidepressants and those substances included i n t h e r a p e u t i c m o n i t o r i n g programs.
Time honored c l a s s i c a l spot t e s t s and m i c r o d i f f u s i o n techniques can i d e n t i f y many o f these substances. C l a s s i c a l t h i n l a y e r chromatography has seen many new advances.
Today semi-automated procedures a r e a v a i l a b l e t h a t w i l l separate t h e analytes from t h e i r b i o l o g i c a l m a t r i x and proceed w i t h s p o t t i n g and development. Another i n n o v a t i o n t h a t helps r e l a t i v e l y naive a n a l y s t s i n t e r p r e t t h e chromatogram i s a computerized data analysis instrument.
Has an employee been using drugs? Laboratories a r e asked One b a s i s f o r an answer C l i n i c i a n s presume t h a t
Seldom Most l a b o r a t o r i e s depreciate t h e l a b o r a t o r y ' s a b i l i t y t o provide
To s i m p l i f y t h e For 1 year, o u r l a b o r a t o r y compared t h e p h y s i c i a n ' s requests w i t h
One t h i r d o f t h e time, the p h y s i c i a n ' s presumption was c o r r e c t ,
These data suggest t h a t t h e p h u s i c i a n ' s I
minutes. From h i s b r i e f p r e s e n t a t i o n you w i l l l e a r n t h a t a reasonably s t a f f e d and equipped l a b o r a t o r y can p r o v i d e acceptable r e p o r t s t h a t can be h e l p f u l t o a c l i n i c i a n concerned w i t h t h e diagnosis and treatment o f a p a t i e n t suspected t o be a v i c t i m o f poisoning.
The second o f t h e two questions o r i g i n a l l y proposed r e f l e c t s growing s o c i e t a l concerns about drug abuse. employees t o t e s t s designed t o i n d i c a t e i f t h e y a r e using s p e c i f i e d substances t h a t a r e considered t o be undesirable and d e t r i m e n t a l . d i f f e r e n t approach t o t h a t j u s t suggested f o r c l i n i c a l t o x i c o l o g y which concerns i n f r e q u e n t a n a l y s i s o f blood and/or u r i n e f o r many analytes. number u r i n e specimens t h a t a r e t o be analyzed f o r a l i m i t e d number ( 3 t o 8) substances. The number o f specimens processed a drug t e s t i n g l a b o r a t o r y v a r i e s from 100 t o 5000. S p e c i f i c i t y and s e n s i t i v i t y demands a r e high, as i s t h e n e c e s s i t y t o meet f o r e n s i c c r i t e r i a . q u a l i t y assurance standards. Not o n l y must each batch o f specimens c o n t a i n negative and p o s i t i v e c o n t r o l s and a c a l i b r a t o r b u t i n t e r n a l and e x t e r n a l b l i n d specimens a r e a l s o required.
Novel techniques a r e r e q u i r e d t o meet t h i s challenge. One such i s bar coding. Each specimen i s l a b e l l e d w i t h a b a r code wich n o t o n l y i d e n t i f i e s the specimen b u t a l s o i n d i c a t e s which analytes a r e t o be t e s t e d when the specimen i s placed i n a s u i t a b l e automated chemical analyzer. o f processing up t o 120 t o 300 specimens an hour f o r up t o 10 analytes i n each specimen. Admittedly these instruments a r e v e r y expensive b u t t h e i r c o s t i s e a s i l y amortized by t h e i r h i g h volume throughput and minimal demands f o r specimen and reagent volumes. Some l a b o r a t o r i e s r e p o r t t h e i r c o s t f o r reagents f o r 1 t e s t approximates $0.05. e f f i c i e n t u n i t s can be used f o r i n i t i a l immunoassays which i s o l a t e presumptive p o s i t i v e s and p e r m i t the r e j e c t i o n o f t h e negatives.
The presumptive p o s i t i v e s must be confirmed by GC/MS, i f present standards a r e t o be met. Modern advances p e r m i t r o b o t i c processing o f t h e specimens so t h a t t h e drug i s i s o l a t e d from t h e u r i n e m a t r i x , d e r i v a t i z e d , and a s u i t a b l e a l i q u o t i s analyzed by GC/MS, which can be accomplished w i t h automatic sample handling equipment. r e t r i e v e s t h e r e s u l t i n g data and y i e l d s q u a n t i t a t i v e data based on r i g i d s p e c i f i c a t i o n s f o r a c c e p t a b i l i t y .
The e x a c t i n g steps i n t h e p r e p a r a t i o n o f m a t e r i a l s u i t a b l e f o r GC/MS a n a l y s i s can be, and u s u a l l y i s , performed by s k i l l e d a n a l y s t s r a t h e r t h a t by a r o b o t whose time has n o t y e t come. O r . Gelpi p o i n t s o u t t h e r e a r e many compounds t h a t are more amenable t o HPLC than GC -t h e anabolic s t e r i o d s f o r one example.
w i t h p a i n s t a k i n g care, v e r y small amounts o f these compounds can be r e l i a b l y q u a n t i t a t e d using HPLC/MS. H i s p r e s e n t a t i o n w i l l a m p l i f y these i n t r o d u c t o r y remarks.
Having demonstrated t h a t specimens can be analyzed accurately, the i n t e r p r e t a t i o n o f the r e s u l t i s a r e a l challenge. Only one aspect o f t h a t problem w i l l be discussed now. i n t h e racemic m i x t u r e s o f drugs i n common use.
Recognition t h a t enantomers o f drugs have d i f f e r e n t pharmacological p r o p e r t i e s has l e d t o the development o f methods f o r t h e i r separation. as racemates, m i x t u r e s o f two enantiomers. One, t h e eutomer, i s more a c t i v e than t h e other, the d i s t o n e r .
o f t h e eutomer exceed those f o r t h e racemate, e f f o r t s w i l l be made t o produce and market t h e more e f f e c t i v e eutomer. and D r . P o r t e r presents t h a t m a t e r i a l i n h i s t r e a t i s e .
I have presented an overview o f some new a n a l y t i c a l techniques t h a t w i l l lead t o improved l a b o r a t o r y performances. My colleagues w i l l present more d e t a i l s .
More and more companies a r e s u b j e c t i n g t h e i r employees and prospective Solving t h i s problem r e q u i r e s a Drug abuse programs i n v o l v e a l a r g e
The mandate thorough documentation o f each step i n t h e a n a l y s i s under r i g i d
One f a l s e p o s i t i v e r e p o r t i s t h e b a s i s f o r d i s c r e d i t i n g a l a b o r a t o r y .
These instruments a r e remarkably r e l i a b l e and are capable These A computer
Again
That problem r e l a t e s t o assessing t h e r e l a t i v e a c t i v i t y o f t h e two forms present
Most drugs a r e p r e s e n t l y s o l d
As evidence i s developed t o i n d i c a t e t h a t the therapeutic advantages
Methods have been developed t h a t p e r m i t these separations,
